| 1 | Uterine Neoplasms | 43.4% |
| 2 | Vaginal Neoplasms | 43.4% |
| 3 | Vulvar Neoplasms | 43.4% |
| 4 | Uterine Cancer | 43.4% |
| 5 | Salpingitis | 35.1% |
| 6 | Endometrial Neoplasms | 31.6% |
| 7 | Carcinoma, Endometrioid | 28.9% |
| 8 | Urologic Neoplasms | 27.3% |
| 9 | ovarian neoplasm | 25.8% |
| 10 | Endometritis | 23.1% |
| 11 | Endometriosis | 21.5% |
| 12 | Uterine Diseases | 21.5% |
| 13 | Vaginal Diseases | 21.5% |
| 14 | Vulvar Diseases | 21.5% |
| 15 | Endometrioma | 21.5% |
| 16 | Oophoritis | 20.9% |
| 17 | Urologic Diseases | 19.6% |
| 18 | Ovarian Diseases | 18.7% |
| 19 | Adnexitis | 18.4% |
| 20 | Pelvic Inflammatory Disease | 18.4% |
| 21 | Infertility | 17.5% |
| 22 | Bladder Neoplasm | 17.4% |
| 23 | Kidney Neoplasm | 17.4% |
| 24 | Ureteral Neoplasms | 17.4% |
| 25 | Urethral Neoplasms | 17.4% |
| 26 | granulosa cell tumor | 17.3% |
| 27 | Carcinoma, Ovarian Epithelial | 17.3% |
| 28 | Urogenital Abnormalities | 16.4% |
| 29 | Parametritis | 15.6% |
| 30 | Pregnancy Complications | 14.9% |
| 31 | Vulvovaginitis | 14.7% |
| 32 | Uterine Inversion | 14.2% |
| 33 | Endometrial Stromal Sarcoma | 14.2% |
| 34 | Corpus Luteum Cyst | 13.4% |
| 35 | Ovarian Cysts | 13.4% |
| 36 | Endometrial Hyperplasia | 13.3% |
| 37 | Pyometra | 13.3% |
| 38 | Vaginitis | 13.3% |
| 39 | Vulvitis | 13.3% |
| 40 | Vaginal Discharge | 13.3% |
| 41 | Vulvodynia | 13.3% |
| 42 | Sexually Transmitted Diseases | 13% |
| 43 | Pregnancy Complications, Neoplastic | 12.7% |
| 44 | Ovarian Hyperstimulation Syndrome | 12.6% |
| 45 | Genital Herpes | 12.5% |
| 46 | Abdominal Neoplasms | 12.3% |
| 47 | Head and Neck Neoplasms | 12.3% |
| 48 | Soft Tissue Neoplasms | 12.3% |
| 49 | Thoracic Neoplasms | 12.3% |
| 50 | Mesoblastic Nephroma | 12.3% |
| 51 | Uterine Rupture | 12.1% |
| 52 | Renal Cell Carcinoma | 11.7% |
| 53 | Papillary Renal Cell Carcinoma | 11.7% |
| 54 | Genital Neoplasms, Male | 11.7% |
| 55 | Nephroblastoma | 11.7% |
| 56 | Bladder Exstrophy | 11.1% |
| 57 | Epispadias | 11.1% |
| 58 | Tuberculosis, Renal | 11% |
| 59 | Urinary Bladder Diseases | 10.9% |
| 60 | Kidney Diseases | 10.9% |
| 61 | Ureteral Diseases | 10.9% |
| 62 | Urethral Diseases | 10.9% |
| 63 | Urination Disorders | 10.9% |
| 64 | Urolithiasis | 10.9% |
| 65 | Pruritus Vulvae | 10.7% |
| 66 | Uterine hemorrhage | 10.7% |
| 67 | Vaginal Fistula | 10.7% |
| 68 | Uterine Prolapse | 10.6% |
| 69 | Vaginal Prolapse | 10.6% |
| 70 | Vesicovaginal Fistula | 10.6% |
| 71 | Anovulation | 10.5% |
| 72 | Premature Menopause | 10.4% |
| 73 | Digestive System Neoplasms | 10.3% |
| 74 | Endocrine Gland Neoplasms | 10.3% |
| 75 | Eye Neoplasms | 10.3% |
| 76 | Nervous System Neoplasms | 10.3% |
| 77 | Bone neoplasms | 10% |
| 78 | Skin Neoplasms | 10% |
| 79 | Hematologic Neoplasms | 10% |
| 80 | Splenic Neoplasms | 9.9% |
| 81 | Multicystic Dysplastic Kidney | 9.8% |
| 82 | Anuria | 9.7% |
| 83 | Ureterolithiasis | 9.7% |
| 84 | Nephrolithiasis | 9.7% |
| 85 | Polycystic Ovary Syndrome | 9.7% |
| 86 | Candidiasis, Vulvovaginal | 9.6% |
| 87 | Uterine Cervical Incompetence | 9.6% |
| 88 | Uterine Cervicitis | 9.2% |
| 89 | Leukorrhea | 9.2% |
| 90 | Urinary tract infection | 9.2% |
| 91 | Horseshoe Kidney | 9.1% |
| 92 | Dyspareunia | 9% |
| 93 | Parathyroid Neoplasms | 8.6% |
| 94 | Peritoneal Neoplasms | 8.6% |
| 95 | Thyroid Neoplasm | 8.6% |
| 96 | Thyroid carcinoma | 8.6% |
| 97 | Urinary Bladder Fistula | 8.5% |
| 98 | Testicular Neoplasms | 8.4% |
| 99 | Bladder neck obstruction | 8.3% |
| 100 | Denys-Drash Syndrome | 8.2% |
| 101 | Multiple Endocrine Neoplasia | 8% |
| 102 | Hermaphroditism | 7.9% |
| 103 | Disorders of Sex Development | 7.9% |
| 104 | Polyhydramnios | 7.8% |
| 105 | Obstetric Labor Complications | 7.8% |
| 106 | Ectopic Pregnancy | 7.8% |
| 107 | Pregnancy, Prolonged | 7.8% |
| 108 | Puerperal Disorders | 7.8% |
| 109 | Oligohydramnios | 7.8% |
| 110 | Prenatal Injuries | 7.8% |
| 111 | Hypospadias | 7.8% |
| 112 | Paraneoplastic Encephalomyelitis | 7.8% |
| 113 | Mammary Neoplasms, Experimental | 7.7% |
| 114 | Hamartoma | 7.7% |
| 115 | Neoplasms, Hormone-Dependent | 7.7% |
| 116 | Neoplasms, Multiple Primary | 7.7% |
| 117 | Paraneoplastic Syndromes | 7.7% |
| 118 | Precancerous Conditions | 7.7% |
| 119 | Neoplasms, Second Primary | 7.7% |
| 120 | Pancreatic Neoplasm | 7.6% |
| 121 | Bacterial Vaginosis | 7.5% |
| 122 | Trophoblastic Neoplasms | 7.4% |
| 123 | Trichomonas Vaginitis | 7.4% |
| 124 | Uterine Perforation | 7.4% |
| 125 | Metrorrhagia | 7.4% |
| 126 | Retroperitoneal Neoplasms | 7.3% |
| 127 | Kidney Calculi | 7.2% |
| 128 | Ureteral Calculi | 7.2% |
| 129 | Abruptio Placentae | 7.2% |
| 130 | Placenta Accreta | 7.2% |
| 131 | Tracheal Neoplasms | 7.1% |
| 132 | Acanthoma | 7.1% |
| 133 | Chorioamnionitis | 6.8% |
| 134 | Cystitis | 6.8% |
| 135 | Hydronephrosis | 6.8% |
| 136 | Hyperoxaluria | 6.8% |
| 137 | Kidney Cortex Necrosis | 6.8% |
| 138 | Kidney Papillary Necrosis | 6.8% |
| 139 | Nephritis | 6.8% |
| 140 | Nephrosclerosis | 6.8% |
| 141 | Nephrosis | 6.8% |
| 142 | Perinephritis | 6.8% |
| 143 | Kidney Failure | 6.8% |
| 144 | Uremia | 6.8% |
| 145 | Ureteral obstruction | 6.8% |
| 146 | Ureterocele | 6.8% |
| 147 | Urethral Obstruction | 6.8% |
| 148 | Urethritis | 6.8% |
| 149 | Vesico-Ureteral Reflux | 6.8% |
| 150 | Urinary Retention | 6.8% |
| 151 | Oxalosis | 6.8% |
| 152 | Renal Insufficiency | 6.8% |
| 153 | Fetal Diseases | 6.5% |
| 154 | Pregnancy Complications, Cardiovascular | 6.5% |
| 155 | Penile Neoplasms | 6.5% |
| 156 | Prostatic Neoplasms | 6.5% |
| 157 | Pregnancy Complications, Hematologic | 6.4% |
| 158 | Pregnancy Complications, Infectious | 6.4% |
| 159 | Fetal Death | 6.3% |
| 160 | Perinatal death | 6.3% |
| 161 | Morning Sickness | 6.2% |
| 162 | Cyst | 6.2% |
| 163 | Neoplastic Processes | 6.2% |
| 164 | Neoplastic Syndromes, Hereditary | 6.2% |
| 165 | Menorrhagia | 6.2% |
| 166 | Pyelocystitis | 6.2% |
| 167 | Esophageal Neoplasms | 6.1% |
| 168 | Neoplasms, Experimental | 6.1% |
| 169 | Puerperal Infection | 6% |
| 170 | Postpartum Hemorrhage | 6% |
| 171 | Mouth Neoplasms | 5.9% |
| 172 | Central Nervous System Neoplasms | 5.9% |
| 173 | Vascular Neoplasms | 5.9% |
| 174 | Thymus Neoplasms | 5.9% |
| 175 | Breast Neoplasms, Male | 5.8% |
| 176 | Triple Negative Breast Neoplasms | 5.8% |
| 177 | Carcinoma, Lobular | 5.8% |
| 178 | Diabetes Insipidus | 5.8% |
| 179 | Hepatorenal Syndrome | 5.8% |
| 180 | Bacteriuria | 5.7% |
| 181 | Diabetic Nephropathy | 5.7% |
| 182 | Glycosuria | 5.7% |
| 183 | Hematuria | 5.7% |
| 184 | Renal hypertension | 5.7% |
| 185 | Oliguria | 5.7% |
| 186 | Polyuria | 5.7% |
| 187 | Proteinuria | 5.7% |
| 188 | Pyuria | 5.7% |
| 189 | Renal Artery Obstruction | 5.7% |
| 190 | Renal Artery Stenosis | 5.7% |
| 191 | Urinary Calculi | 5.7% |
| 192 | Cystocele | 5.7% |
| 193 | Nephrocalcinosis | 5.7% |
| 194 | Urinary Incontinence | 5.7% |
| 195 | Thyroid Nodule | 5.6% |
| 196 | Pyelonephritis | 5.5% |
| 197 | Gestational Diabetes | 5.3% |
| 198 | Neoplasms, Radiation-Induced | 5.1% |
| 199 | Adrenal Gland Neoplasms | 5% |
| 200 | Gastrointestinal Neoplasms | 5% |
| 201 | Liver neoplasms | 5% |
| 202 | Uveal Neoplasms | 5% |
| 203 | Enuresis | 4.9% |
| 204 | Sebaceous Gland Neoplasms | 4.9% |
| 205 | Spinal Neoplasms | 4.9% |
| 206 | Bone Marrow Neoplasms | 4.9% |
| 207 | Multiple Endocrine Neoplasia Type 1 | 4.9% |
| 208 | Genital Neoplasms, Female | 4.9% |
| 209 | Thymoma | 4.9% |
| 210 | Gonadal Dysgenesis | 4.9% |
| 211 | Adrenogenital Syndrome | 4.9% |
| 212 | Ovotesticular Disorders of Sex Development | 4.9% |
| 213 | Meningioma | 4.9% |
| 214 | Prostatic Neoplasms, Castration-Resistant | 4.8% |
| 215 | Glycosuria, Renal | 4.8% |
| 216 | Fallopian Tube Neoplasms | 4.8% |
| 217 | Glomerulonephritis | 4.8% |
| 218 | Nephritis, Interstitial | 4.8% |
| 219 | Lipoid nephrosis | 4.8% |
| 220 | Nephrotic Syndrome | 4.8% |
| 221 | Pyelitis | 4.8% |
| 222 | Pyonephrosis | 4.8% |
| 223 | Urethral Stenosis | 4.8% |
| 224 | Nephrogenic Diabetes Insipidus | 4.8% |
| 225 | Congenital Nephrogenic Diabetes Insipidus | 4.8% |
| 226 | Acute kidney injury | 4.8% |
| 227 | Urethral stricture | 4.8% |
| 228 | Carcinoma, Pancreatic Ductal | 4.8% |
| 229 | Leydig Cell Tumor | 4.7% |
| 230 | Chlamydia Infections | 4.6% |
| 231 | Gonorrhea | 4.6% |
| 232 | Carcinoma 256, Walker | 4.6% |
| 233 | Choriocarcinoma | 4.6% |
| 234 | Carcinoma, Ehrlich Tumor | 4.6% |
| 235 | Dermoid Cyst | 4.6% |
| 236 | Carcinoma, Lewis Lung | 4.6% |
| 237 | Liver Neoplasms, Experimental | 4.5% |
| 238 | Abortion, Habitual | 4.5% |
| 239 | Dystocia | 4.5% |
| 240 | Eclampsia | 4.5% |
| 241 | Fetal Membranes, Premature Rupture | 4.5% |
| 242 | Placental Insufficiency | 4.5% |
| 243 | Pre-Eclampsia | 4.5% |
| 244 | Prenatal Exposure Delayed Effects | 4.5% |
| 245 | HELLP Syndrome | 4.5% |
| 246 | Placenta, Retained | 4.5% |
| 247 | Leukemia, Experimental | 4.4% |
| 248 | Hyperandrogenism | 4.4% |
| 249 | AIDS-Associated Nephropathy | 4.3% |
| 250 | Leukoplakia, Oral | 4.2% |
| 251 | Tuberous Sclerosis | 4.2% |
| 252 | Paraneoplastic Cerebellar Degeneration | 4.2% |
| 253 | Syphilis | 4.1% |
| 254 | Erythroplasia | 4.1% |
| 255 | Follicular cyst | 4.1% |
| 256 | leukemia | 4.1% |
| 257 | Mucocele | 4.1% |
| 258 | Neoplasms, Germ Cell and Embryonal | 4.1% |
| 259 | Neoplasms, Glandular and Epithelial | 4.1% |
| 260 | Pilonidal Cyst | 4.1% |
| 261 | Thyroglossal Cyst | 4.1% |
| 262 | Synovial Cyst | 4.1% |
| 263 | Germ Cell Cancer | 4.1% |
| 264 | Aberrant Crypt Foci | 4.1% |
| 265 | Azotemia | 4.1% |
| 266 | Nose Neoplasms | 4% |
| 267 | Albuminuria | 4% |
| 268 | Hemoglobinuria | 4% |
| 269 | Hypertension, Renovascular | 4% |
| 270 | Urge Incontinence | 4% |
| 271 | Neuroectodermal Tumors | 3.9% |
| 272 | Meningeal Neoplasms | 3.9% |
| 273 | Acoustic Neuroma | 3.8% |
| 274 | Melanoma, Experimental | 3.8% |
| 275 | Balkan Nephropathy | 3.8% |
| 276 | Focal glomerulosclerosis | 3.8% |
| 277 | Kidney Failure, Chronic | 3.8% |
| 278 | Sarcoma, Experimental | 3.8% |
| 279 | Leukemia, Radiation-Induced | 3.8% |
| 280 | Palatal Neoplasms | 3.8% |
| 281 | Neoplasms, Neuroepithelial | 3.8% |
| 282 | Gliomatosis cerebri | 3.8% |
| 283 | insulinoma | 3.7% |
| 284 | Abortion, Veterinary | 3.7% |
| 285 | Pregnancy Complications, Parasitic | 3.7% |
| 286 | Hepatocellular Adenoma | 3.7% |
| 287 | Vipoma | 3.7% |
| 288 | Pituitary Adenoma | 3.7% |
| 289 | Pituitary Neoplasms | 3.7% |
| 290 | Limbic Encephalitis | 3.7% |
| 291 | Gastrinoma | 3.6% |
| 292 | Glucagonoma | 3.6% |
| 293 | Lymphogranuloma Venereum | 3.6% |
| 294 | Retinoblastoma | 3.6% |
| 295 | Lactation Disorder | 3.6% |
| 296 | Mastitis | 3.6% |
| 297 | Depression, Postpartum | 3.6% |
| 298 | Embryo Loss | 3.6% |
| 299 | Fetal Resorption | 3.6% |
| 300 | Hyperemesis Gravidarum | 3.5% |
| 301 | Polycystic Kidney Diseases | 3.5% |
| 302 | Diurnal Enuresis | 3.5% |
| 303 | Renal Aminoacidurias | 3.4% |
| 304 | Fanconi Syndrome | 3.4% |
| 305 | Pseudohypoaldosteronism | 3.4% |
| 306 | Liddle Syndrome | 3.4% |
| 307 | Hemolytic-Uremic Syndrome | 3.4% |
| 308 | Renal Osteodystrophy | 3.4% |
| 309 | Renal rickets | 3.4% |
| 310 | Leukoplakia | 3.3% |
| 311 | Lymphocele | 3.3% |
| 312 | Pancreatic Cyst | 3.3% |
| 313 | Ear Neoplasms | 3.3% |
| 314 | Eyelid Neoplasms | 3.3% |
| 315 | Lung Neoplasms | 3.3% |
| 316 | Pleural Neoplasms | 3.3% |
| 317 | Glomerulonephritis, Membranoproliferative | 3.3% |
| 318 | Lambert-Eaton Myasthenic Syndrome | 3.3% |
| 319 | Barrett Esophagus | 3.3% |
| 320 | Breast Cyst | 3.3% |
| 321 | Histiocytic Disorders, Malignant | 3.3% |
| 322 | Actinic keratosis | 3.3% |
| 323 | Mediastinal Cyst | 3.3% |
| 324 | Neoplasm Invasiveness | 3.3% |
| 325 | Neoplasm Metastasis | 3.3% |
| 326 | Neoplasm Recurrence, Local | 3.3% |
| 327 | Parovarian Cyst | 3.3% |
| 328 | Pericardial Cyst | 3.3% |
| 329 | Thymic Cyst | 3.3% |
| 330 | Carcinogenesis | 3.3% |
| 331 | Myxoid cyst | 3.3% |
| 332 | Metastasis | 3.3% |
| 333 | Brain Neoplasms | 3.3% |
| 334 | Salivary Gland Neoplasms | 3.3% |
| 335 | Spinal Cord Neoplasms | 3.3% |
| 336 | Tongue Neoplasms | 3.3% |
| 337 | Carcinosarcoma | 3.2% |
| 338 | Hemangiosarcoma | 3.2% |
| 339 | Leukemia L1210 | 3.2% |
| 340 | Leukemia P388 | 3.2% |
| 341 | lymphangiosarcoma | 3.2% |
| 342 | Prolactinoma | 3.2% |
| 343 | Growth Hormone-Secreting Pituitary Adenoma | 3.2% |
| 344 | melanoma | 3.2% |
| 345 | Hydatidiform Mole | 3.2% |
| 346 | Fetal Growth Retardation | 3% |
| 347 | Optic Nerve Glioma | 3% |
| 348 | Turner Syndrome | 3% |
| 349 | Embolism, Amniotic Fluid | 3% |
| 350 | Fetal Hypoxia | 3% |
| 351 | Fetal Alcohol Spectrum Disorders | 3% |
| 352 | Renal tubular acidosis | 3% |
| 353 | Lymphomatoid Granulomatosis | 3% |
| 354 | Breech Presentation | 3% |
| 355 | Opsoclonus-Myoclonus Syndrome | 3% |
| 356 | Stillbirth | 3% |
| 357 | Sarcoma 180 | 2.9% |
| 358 | Meningeal Carcinomatosis | 2.9% |
| 359 | Pharyngeal Neoplasms | 2.9% |
| 360 | Central Nervous System Cysts | 2.8% |
| 361 | Medulloblastoma | 2.8% |
| 362 | Premature Birth | 2.8% |
| 363 | Bile Duct Neoplasms | 2.8% |
| 364 | gallbladder neoplasm | 2.8% |
| 365 | Intestinal Neoplasms | 2.8% |
| 366 | Stomach Neoplasms | 2.8% |
| 367 | Anti-Glomerular Basement Membrane Disease | 2.8% |
| 368 | Composite Lymphoma | 2.8% |
| 369 | Lupus Nephritis | 2.8% |
| 370 | Polycythemia Vera | 2.8% |
| 371 | Adenomatous Polyposis Coli | 2.8% |
| 372 | Lymphoma | 2.8% |
| 373 | Polycystic Kidney, Autosomal Dominant | 2.7% |
| 374 | Cystinuria | 2.7% |
| 375 | Atypical Hemolytic Uremic Syndrome | 2.7% |
| 376 | Kallmann Syndrome | 2.7% |
| 377 | Leukemia, Plasma Cell | 2.7% |
| 378 | Adenoma, Acidophil | 2.7% |
| 379 | Ganglioneuroma | 2.7% |
| 380 | Glioma | 2.7% |
| 381 | Myelitis, Transverse | 2.7% |
| 382 | Malignant Glioma | 2.7% |
| 383 | Zellweger Syndrome | 2.6% |
| 384 | Basal Cell Nevus Syndrome | 2.6% |
| 385 | Basal cell carcinoma | 2.6% |
| 386 | Carcinoma, Papillary | 2.6% |
| 387 | Squamous cell carcinoma | 2.6% |
| 388 | Chondrosarcoma | 2.6% |
| 389 | Craniopharyngioma | 2.6% |
| 390 | Cystadenoma | 2.6% |
| 391 | leiomyosarcoma | 2.6% |
| 392 | liposarcoma | 2.6% |
| 393 | Mesothelioma | 2.6% |
| 394 | synovial sarcoma | 2.6% |
| 395 | Neuroectodermal Tumor, Melanotic | 2.6% |
| 396 | Angiomyolipoma | 2.6% |
| 397 | Clear Cell Sarcoma of Soft Tissue | 2.6% |
| 398 | Alveolar Soft Part Sarcoma | 2.6% |
| 399 | Neuroendocrine Tumors | 2.6% |
| 400 | Sarcoma, Myeloid | 2.6% |
| 401 | Carcinoma, Basal Cell | 2.6% |
| 402 | Laryngeal neoplasm | 2.5% |
| 403 | Bronchial Neoplasms | 2.5% |
| 404 | Multiple Pulmonary Nodules | 2.4% |
| 405 | Adenoma | 2.4% |
| 406 | Ameloblastoma | 2.4% |
| 407 | Angiokeratoma | 2.4% |
| 408 | Carcinoma | 2.4% |
| 409 | Chordoma | 2.4% |
| 410 | Hemangioma | 2.4% |
| 411 | hemangiopericytoma | 2.4% |
| 412 | Lymphangioma | 2.4% |
| 413 | Mesenchymoma | 2.4% |
| 414 | Nevus | 2.4% |
| 415 | Teratoma | 2.4% |
| 416 | Hepatoblastoma | 2.4% |
| 417 | Mixed Tumor, Mullerian | 2.4% |
| 418 | Germinoma | 2.4% |
| 419 | Teratocarcinoma | 2.4% |
| 420 | Angiofibroma | 2.4% |
| 421 | Sarcoma | 2.4% |
| 422 | Epithelioma | 2.4% |
| 423 | Hyperphosphaturia | 2.4% |
| 424 | Klinefelter Syndrome | 2.4% |
| 425 | Supratentorial Neoplasms | 2.4% |
| 426 | Adrenocortical carcinoma | 2.4% |
| 427 | Carcinoid Tumor | 2.4% |
| 428 | Neurilemmoma | 2.4% |
| 429 | Hutchinson's Melanotic Freckle | 2.4% |
| 430 | Melanoma, Amelanotic | 2.4% |
| 431 | Choledochal Cyst | 2.4% |
| 432 | Peutz-Jeghers Syndrome | 2.3% |
| 433 | Meconium Aspiration Syndrome | 2.3% |
| 434 | Galactorrhea | 2.3% |
| 435 | Cystadenocarcinoma | 2.2% |
| 436 | Fibrosarcoma | 2.2% |
| 437 | Osteosarcoma | 2.2% |
| 438 | Mucoepidermoid Carcinoma | 2.2% |
| 439 | Astrocytoma | 2.1% |
| 440 | Ependymoma | 2.1% |
| 441 | oligodendroglioma | 2.1% |
| 442 | Ganglioglioma | 2.1% |
| 443 | gliosarcoma | 2.1% |
| 444 | Anaplastic astrocytoma | 2.1% |
| 445 | Anaplastic Oligodendroglioma | 2.1% |
| 446 | Hypopharyngeal Neoplasms | 2.1% |
| 447 | Pleural Effusion, Malignant | 2.1% |
| 448 | Hypopharyngeal Cancer | 2.1% |
| 449 | Adenofibroma | 2.1% |
| 450 | Fibroadenoma | 2.1% |
| 451 | Malignant Fibrous Histiocytoma | 2.1% |
| 452 | Parotid Neoplasms | 2.1% |
| 453 | Nelson Syndrome | 2.1% |
| 454 | Brain Stem Neoplasms | 2% |
| 455 | Malignant Carcinoid Syndrome | 2% |
| 456 | Pancreatic Pseudocyst | 2% |
| 457 | Plasmacytoma | 2% |
| 458 | Malignant histiocytosis | 1.9% |
| 459 | Lymphatic Metastasis | 1.9% |
| 460 | Neoplasms, Unknown Primary | 1.9% |
| 461 | Leukemic Infiltration | 1.9% |
| 462 | Histiocytic sarcoma | 1.9% |
| 463 | Neoplasm Micrometastasis | 1.9% |
| 464 | Bowen's Disease | 1.9% |
| 465 | Paraganglioma | 1.9% |
| 466 | Rhabdomyosarcoma | 1.9% |
| 467 | Giant Cell Tumor of Bone | 1.9% |
| 468 | Glioblastoma | 1.9% |
| 469 | Neuroblastoma | 1.9% |
| 470 | Glioblastoma Multiforme | 1.9% |
| 471 | Nasopharyngeal carcinoma | 1.8% |
| 472 | Lymphangioleiomyomatosis | 1.8% |
| 473 | Cecal Neoplasms | 1.8% |
| 474 | Duodenal Neoplasms | 1.8% |
| 475 | Choroid Plexus Papilloma | 1.8% |
| 476 | Dermatofibrosarcoma | 1.8% |
| 477 | Dermatofibrosarcoma Protuberans | 1.8% |
| 478 | Tonsillar Neoplasms | 1.7% |
| 479 | Ganglioneuroblastoma | 1.7% |
| 480 | Cerebellar Neoplasms | 1.7% |
| 481 | Neurofibrosarcoma | 1.7% |
| 482 | Nasopharyngeal Neoplasms | 1.6% |
| 483 | Hodgkin Disease | 1.6% |
| 484 | Lymphoma, Non-Hodgkin | 1.6% |
| 485 | Colorectal Neoplasms | 1.6% |
| 486 | Adenocarcinoma | 1.6% |
| 487 | Carcinoma in Situ | 1.6% |
| 488 | Carcinoma, Transitional Cell | 1.6% |
| 489 | Phyllodes Tumor | 1.6% |
| 490 | Dysgerminoma | 1.6% |
| 491 | Hemangioendothelioma | 1.6% |
| 492 | Lipoma | 1.6% |
| 493 | Myoma | 1.6% |
| 494 | Myxoma | 1.6% |
| 495 | Neuroma | 1.6% |
| 496 | Papilloma | 1.6% |
| 497 | Pseudomyxoma Peritonei | 1.6% |
| 498 | Seminoma | 1.6% |
| 499 | Papillomatosis | 1.6% |
| 500 | Angiolipoma | 1.6% |
| 501 | Myelolipoma | 1.6% |
| 502 | Neoplasms, Bone Tissue | 1.6% |
| 503 | Neoplasms, Fibrous Tissue | 1.6% |
| 504 | Smooth Muscle Tumor | 1.6% |
| 505 | Adenomatosis, Pulmonary | 1.6% |
| 506 | Adenomatous Polyps | 1.6% |
| 507 | Carcinoma, Large Cell | 1.6% |
| 508 | Carcinoma, Small Cell | 1.6% |
| 509 | Desmoplastic Small Round Cell Tumor | 1.6% |
| 510 | Chondroma | 1.6% |
| 511 | Enchondroma | 1.6% |
| 512 | Pheochromocytoma | 1.6% |
| 513 | Alveolar rhabdomyosarcoma | 1.6% |
| 514 | Carcinoid Heart Disease | 1.6% |
| 515 | Xeroderma Pigmentosum | 1.5% |
| 516 | Appendiceal Neoplasms | 1.5% |
| 517 | Colonic Neoplasms | 1.5% |
| 518 | Rectal Neoplasms | 1.5% |
| 519 | Paranasal Sinus Neoplasms | 1.5% |
| 520 | Primary amyloidosis | 1.4% |
| 521 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 522 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 523 | Familial Hypophosphatemic Rickets | 1.3% |
| 524 | Maxillary Sinus Neoplasms | 1.2% |
| 525 | Adenoid Cystic Carcinoma | 1.2% |
| 526 | fibroma | 1.2% |
| 527 | Fibromatosis | 1.2% |
| 528 | Osteoblastoma | 1.2% |
| 529 | Osteoma | 1.2% |
| 530 | Rhabdomyoma | 1.2% |
| 531 | Chondromatosis | 1.2% |
| 532 | Adenocarcinoma, Clear Cell | 1.2% |
| 533 | Cholangiocarcinoma | 1.2% |
| 534 | Cervical Intraepithelial Neoplasia | 1.2% |
| 535 | Hemangioblastoma | 1.2% |
| 536 | Lymphoma, Extranodal NK-T-Cell | 1.2% |
| 537 | Anus Neoplasms | 1.2% |
| 538 | Sigmoid Neoplasms | 1.2% |
| 539 | Hydrops Fetalis | 1.1% |
| 540 | Mastocytosis | 1.1% |
| 541 | Sturge-Weber Syndrome | 1.1% |
| 542 | Waldenstrom Macroglobulinemia | 1.1% |
| 543 | Multiple Myeloma | 1.1% |
| 544 | Cell Transformation, Viral | 1.1% |
| 545 | Gastrointestinal Stromal Tumors | 1.1% |
| 546 | Hemangioma, Cavernous | 1.1% |
| 547 | Leukemia, T-Cell | 1.1% |
| 548 | Leukemia, B-Cell | 1.1% |
| 549 | neurofibroma | 1.1% |
| 550 | Lymphoma, Follicular | 1.1% |
| 551 | T-Cell Lymphoma | 1.1% |
| 552 | Mantle cell lymphoma | 1.1% |
| 553 | Fibromatosis, Aggressive | 1% |
| 554 | Fibromatosis, Abdominal | 1% |
| 555 | Klatskin Tumor | 1% |
| 556 | Zollinger-Ellison syndrome | 1% |
| 557 | Mastocytoma | 1% |
| 558 | Mastocytosis, Systemic | 1% |
| 559 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 560 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 561 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 562 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 563 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 564 | Lymphoma, AIDS-Related | 0.8% |
| 565 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 566 | Primary Effusion Lymphoma | 0.8% |
| 567 | Dupuytren Contracture | 0.7% |
| 568 | Urticaria Pigmentosa | 0.7% |
| 569 | Mycosis Fungoides | 0.7% |
| 570 | Lymphomatoid Papulosis | 0.7% |
| 571 | Plasmablastic lymphoma | 0.7% |
| 572 | Burkitt Lymphoma | 0.6% |
| 573 | Sezary Syndrome | 0.5% |
| 574 | Radicular Cyst | 0.5% |